Development of anti-HER2-targeted doxorubicin–core-shell chitosan nanoparticles for the treatment of human breast cancer
Parichart Naruphontjirakul,1 Kwanchanok Viravaidya-Pasuwat1,21Biological Engineering Program, Faculty of Engineering, King Mongkut’s University of Technology Thonburi, Bangkok, Thailand; 2Department of Chemical Engineering, Faculty of Engineering, King Mongkut’s University of Tec...
Saved in:
Main Authors: | Naruphontjirakul P, Viravaidya-Pasuwat K |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2019
|
Subjects: | |
Online Access: | https://doaj.org/article/e14f08e3fa7345429becd538c80dd2b7 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dual-Ligand Functionalized Core-Shell Chitosan-Based Nanocarrier for Hepatocellular Carcinoma-Targeted Drug Delivery
by: Hefnawy A, et al.
Published: (2020) -
Tumor microenvironment dual-responsive core–shell nanoparticles with hyaluronic acid-shield for efficient co-delivery of doxorubicin and plasmid DNA
by: Wang T, et al.
Published: (2017) -
Amphiphilic core shell nanoparticles containing dense polyethyleneimine shells for efficient delivery of microRNA to Kupffer cells
by: Liu Z, et al.
Published: (2016) -
The mini-review for synthesis of core@Ag nanocomposite
by: Rui Wu, et al.
Published: (2022) -
Toughening polylactide using epoxy-functionalized core-shell starch nanoparticles
by: Xinyi Dong, et al.
Published: (2021)